File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Editorial: Epigenetic mechanisms and post-translational modifications as novel therapeutic targets in cancer

TitleEditorial: Epigenetic mechanisms and post-translational modifications as novel therapeutic targets in cancer
Authors
Shi, ZhiWang, NingZhang, Ying JieZheng, Yi Chao
Keywordscancer
epigenetic mechanisms
methylation
post-translational modifications
targets
Issue Date8-Aug-2022
PublisherFrontiers Media
Citation
Frontiers in Pharmacology, 2022, v. 13 How to Cite?
DOI: http://dx.doi.org/10.3389/fphar.2022.988334
Persistent Identifierhttp://hdl.handle.net/10722/344286
ISI Accession Number ID
WOS:000843644700001

 

DC FieldValueLanguage
dc.contributor.authorShi, Zhi-
dc.contributor.authorWang, Ning-
dc.contributor.authorZhang, Ying Jie-
dc.contributor.authorZheng, Yi Chao-
dc.date.accessioned2024-07-16T03:42:16Z-
dc.date.available2024-07-16T03:42:16Z-
dc.date.issued2022-08-08-
dc.identifier.citationFrontiers in Pharmacology, 2022, v. 13-
dc.identifier.urihttp://hdl.handle.net/10722/344286-
dc.languageeng-
dc.publisherFrontiers Media-
dc.relation.ispartofFrontiers in Pharmacology-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.subjectcancer-
dc.subjectepigenetic mechanisms-
dc.subjectmethylation-
dc.subjectpost-translational modifications-
dc.subjecttargets-
dc.titleEditorial: Epigenetic mechanisms and post-translational modifications as novel therapeutic targets in cancer-
dc.typeArticle-
dc.identifier.doi10.3389/fphar.2022.988334-
dc.identifier.scopuseid_2-s2.0-85136518519-
dc.identifier.volume13-
dc.identifier.eissn1663-9812-
dc.identifier.isiWOS:000843644700001-
dc.identifier.issnl1663-9812-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats